Free online searchable
2009 ICD-9-CM
Diseases and Injuries
>> Tabular
Index
>> Alphabetic
Index
Procedures
>> Tabular
Index
>>
Alphabetic Index
Appendices
>> Drugs
/ Chemicals
>> External Causes
Other Resources
>> HCPCS Alpha
>> Medical
Dictionary
>> Drug Directory
Tips
Contribute
V07.5 Prophylactic use of agents affecting estrogen receptors and estrogen levels
Code first, if applicable:
malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
malignant neoplasm of prostate (185)
Use additional code, if applicable, to identify:
estrogen receptor positive status (V86.0)
family history of breast cancer (V16.3)
genetic susceptibility to cancer (V84.01-V84.09)
personal history of breast cancer (V10.3)
personal history of prostate cancer (V10.46)
postmenopausal status (V49.81)
Excludes: hormone replacement therapy (postmenopausal) (V07.4) | |
 eicd10 | V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs)
Prophylactic use of:
raloxifene (Evista)
tamoxifen (Nolvadex)
toremifene (Fareston) |
| eicd10 | V07.52 Prophylactic use of aromatase inhibitors
Prophylactic use of:
anastrozole (Arimidex)
exemestar (Aromasin)
letrozole (Femara) |
| eicd10 | V07.59 Prophylactic use of other agents affecting estrogen receptors and estrogen levels
Prophylactic use of:
estrogen receptor downregulators
fulvestrant (Faslodex)
gonadotropin-releasing hormone (GnRH) agonist
goserelin acetate (Zoladex)
leuprolide acetate (leuprorelin) (Lupron)
megestrol acetate (Megace) |